Rosetta Genomics Ltd. (ROSGQ)
Uses microRNA tests to identify cancer types and track tumor recurrence in patients.
$0.00+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+0.0%
The outlook
ROSGQ is trading at its 52-week low with a mixed price trend relative to its moving averages. The StockGlow score leans heavily bearish at 22/100, reflecting weak sentiment overall. Analyst coverage appears unavailable or minimal for this micro-cap stock.
What’s behind the score
Price trendMixed vs its moving averages
52-week range0% of the way from its 52-week low to high
Market cap
$592
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—